Nomura Securities Assumes Amazon.com (AMZN) at Buy, $950 PT
- Wall Street dips on Trump protectionism, Qualcomm drag
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- Aetna's (AET) Humana (HUM) Takeover Blocked by Judge as Anticompetative
- Trump signs order withdrawing U.S. from Trans-Pacific trade deal
- After-Hours Stock Movers 1/23: (REXX) (MRCY) (SYNC) Higher; (FSM) (OCUL) (CASC) Lower (more...)
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Nomura Securities assumes coverage on Amazon.com (NASDAQ: AMZN) with a Buy rating and a price target of $950.00.
Analyst Anthony DiClemente commented, "Amazon possesses a dominant leadership position in multiple large and global addressable markets. First, in e-commerce, AMZN is a beneficiary of the secular shift from the $24tn global retail market to the $2tn e-commerce market. We estimate that every 1% of this market could represent ~$15bn/~$0.65 in incremental revenue/EPS to AMZN. AMZN is focused on growth of Prime memberships via investment in continuously improving service; aggressive growth in investment in Prime Instant Video (PIV) is a key piece of this strategy. Finally, AMZN’s leadership in the cloud industry via AWS will afford substantial benefits as the market steadily shifts from the ~$145bn on-premise infrastructure software market to the IaaS/PaaS market. We expect EBITDA, EPS, and FCF to grow at CAGRs of 38%, 100% and 45%, respectively, from 2015A-2020E. This industryleading growth supports our target valuation of 24x 2017E EBITDA and $950 TP. "
Shares of Amazon.com closed at $799.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aegis Capital Starts Amazon.com (AMZN) at Buy
- Teradyne (TER) PT Raised to $28 at Deutsche Bank; Reiterates Buy
- CytoSorbents (CTSO) PT Raised to $10 at Maxim Group
Create E-mail Alert Related CategoriesAnalyst Comments, New Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!